Yayın:
In Vitro Evaluation of Sustained Released Matrix Tablet Formulations of Clarithromvcin

Sadeleştirilmiş öğe sayfası
dc.contributor.authorGenç, Lütfı
dc.contributor.authorKiran, A Mrudula
dc.date.accessioned2025-11-13T21:30:32Z
dc.date.issued2005-03-30
dc.identifier.doihttps://doi.org/10.3797/scipharm.aut-05-05
dc.identifier.endpage74
dc.identifier.issn0036-8709
dc.identifier.issue1
dc.identifier.openalexW2512104789
dc.identifier.startpage59
dc.identifier.urihttps://hdl.handle.net/11421/13677
dc.identifier.urihttps://doi.org/10.3797/scipharm.aut-05-05
dc.identifier.volume73
dc.language.isoen
dc.relation.ispartofScientia Pharmaceutica
dc.rightsopenAccess
dc.subjectFriability
dc.subjectFactorial experiment
dc.subjectDissolution
dc.subjectChromatography
dc.subjectMatrix (chemical analysis)
dc.subjectPolymer
dc.subjectClarithromycin
dc.subjectChemistry
dc.subjectDosage form
dc.subjectHigh-performance liquid chromatography
dc.subjectMaterials science
dc.subjectPharmacology
dc.subjectMathematics
dc.subjectMedicine
dc.subjectOrganic chemistry
dc.subjectBiochemistry
dc.subject.sdg12
dc.titleIn Vitro Evaluation of Sustained Released Matrix Tablet Formulations of Clarithromvcin
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5049294391
local.authorid.openalexA5108626813

Dosyalar

Koleksiyonlar

Publications